公开(公告)号：US20230312703A1

公开(公告)日：2023-10-05

申请号：US18128310

申请日：2023-03-30

Applicant: Janssen Biotech, Inc.

Inventor： Daphne Chan ,  Olivia Choi ,  Long-Long Gao ,  Jenny Jeyarajah ,  Shu Li ,  Katelyn Rowland ,  Vikash Sinha ,  Yanli Wang

IPC: C07K16/24 ,  A61K45/06 ,  A61P17/06 ,  A61K9/00

CPC classification number: C07K16/244 ,  A61K45/06 ,  A61P17/06 ,  A61K9/0019 ,  A61K2039/505

Abstract: A method of treating mild to moderate psoriasis in a patient administers an IL-23 specific antibody, e.g., guselkumab, at an initial dose and subsequent doses in order for the patient to respond to the antibody and meet one or more of the clinical endpoints.